Oncology treatment decisions are becoming increasingly complex. With a rise in new innovative therapies and the potential for individualized treatment, the need for strong data-driven evidence and prediction of outcome is increasing. At Precision Health AI we are oncology-focused and driving evidence-based research and analysis to improve care for cancer patients.
Clinical data containing EMR notes, lab results, medical imaging, and genetic sequencing, combined with medical and pharmacy claims provide a granular, temporal representation of a patient. Computational models such as neural networks, bayesian networks, and a variety of supervised and unsupervised ML algorithms provide novel ways to learn patterns and make inferences on that data. This powerful combination of quality data and advanced methods fuels a process of discovery and action on your behalf.
Our data and algorithms enable a more comprehensive longitudinal understanding of cancer, adding clarity to treatment efficacy, patient outcomes, cost, tests/procedures, tumor profiling, and more at a personalized level.Read More
Tools that show treatment plans and the resulting outcomes of sub-populations can drive personalized care for patients, improving patient outcomes and helping providers to manage quality.Read More
Precision Health AI is a platform technology company focused on applications of AI to Oncology. Serving Pharma, Life Sciences, Providers, and Payers PH.AI combines modern AI technology with best in class oncology data with a focus on improving outcomes and driving value based care.
Become the leading provider of AI-enabled technology solutions, with the definitive oncology dataset, and insight/analytics platform to enable precision medicine for oncologists and precision health for pharma, payers, and providers.